Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-26-000017 General Corporate
Debt relative to revenue 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
62.15% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.02% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-24.58% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-37.06% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
86.75% · OPTIONAL · VALID
Gross margin 78th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
47.52% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
20.10% · CORE · VALID
R&D intensity 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.21% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.93% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 68.73%
Current 62.15%
Delta -6.58% Capex Intensity Decreased
Previous 1.54%
Current 1.02%
Delta -0.53% Cash Generation Decreased
Previous 16.21%
Current -24.58%
Delta -40.79% Growth Increased
Previous -51.40%
Current -37.06%
Delta 14.35% Inventory Pressure Increased
Previous 30.35%
Current 86.75%
Delta 56.40% Margin Increased
Previous 42.11%
Current 47.52%
Delta 5.41% Profitability Increased
Previous 6.22%
Current 20.10%
Delta 13.88% R And D Intensity Decreased
Previous 3.18%
Current 2.21%
Delta -0.97% Sbc Intensity Decreased
Previous 1.16%
Current 0.93%
Delta -0.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.